Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Lysine
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lyranda, a Breakthrough Cold Sore Treatment, is Now Available in the U.S.
Details : Lyranda (L-lysine) has antiviral effects by blocking the activity of arginine, which promotes the replication of the herpes simplex virus (HSV).
Product Name : Lyranda
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 28, 2024
Lead Product(s) : Lysine
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable